DANA YESKE: Open Payments
NPI 1972963189 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 22 payments from 16 companies in 2025. Trend: 2023 $848 · 2024 $1,033 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $144 |
| Genmab U.S., Inc. | 1 | $121 |
| Janssen Biotech, Inc. | 3 | $103 |
| AstraZeneca Pharmaceuticals LP | 2 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
| Incyte Corporation | 2 | $50 |
| JAZZ PHARMACEUTICALS INC. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $33 |
| Celgene Corporation | 1 | $33 |
Products named: KEYTRUDA, Epkinly, Onivyde, JAKAFI, TALVEY, ZIIHERA, TECVAYLI, Vyloy.
Industry payments across MD — which companies pay providers there.
